The post AI stock surge raises FOMO warnings from market experts appeared on BitcoinEthereumNews.com. Stock prices tied to artificial intelligence companies might be climbing partly because investors are scared of missing the rally. But financial experts say now’s not the time to bail out. The European Central Bank put out its Financial Stability Review on Wednesday. The report shows worldwide stock markets sitting at consistently high levels. There’s a catch though, a small group of connected American technology giants now dominate the market. That concentration creates conditions where prices could suddenly drop. These dominant players, often called hyperscalers, include Nvidia, Alphabet, Microsoft, and Meta. Current stock prices don’t seem to account for the ongoing risks and uncertain conditions in the market, according to the review. Investors might be feeling hopeful that worst-case scenarios won’t happen. But these price movements could also show people are afraid of missing out on further gains, especially since markets have held up well despite recent problems. Strategists see real value despite FOMO behavior Market analysts have noticed this fear of missing out behavior. Still, they believe genuine value exists in certain AI investments. Julien Lafargue is chief market strategist at Barclays Private Bank and Wealth Management. He pointed out that the ECB’s review aims to highlight possible threats to financial stability, even when the chances of these threats actually happening are small. Prices aren’t cheap, he told CNBC, but companies are showing real growth. Lafargue stressed the need to look carefully at different sectors. The real danger? Companies whose stock prices have jumped without producing any actual earnings yet. He specifically mentioned quantum computing companies. In these situations, investor decisions seem based more on hope than real results, he noted. While fear of missing out might push some prices higher, others reflect genuine earnings growth. That makes careful selection crucial, Lafargue added. Turbulent weeks follow Nvidia earnings The ECB… The post AI stock surge raises FOMO warnings from market experts appeared on BitcoinEthereumNews.com. Stock prices tied to artificial intelligence companies might be climbing partly because investors are scared of missing the rally. But financial experts say now’s not the time to bail out. The European Central Bank put out its Financial Stability Review on Wednesday. The report shows worldwide stock markets sitting at consistently high levels. There’s a catch though, a small group of connected American technology giants now dominate the market. That concentration creates conditions where prices could suddenly drop. These dominant players, often called hyperscalers, include Nvidia, Alphabet, Microsoft, and Meta. Current stock prices don’t seem to account for the ongoing risks and uncertain conditions in the market, according to the review. Investors might be feeling hopeful that worst-case scenarios won’t happen. But these price movements could also show people are afraid of missing out on further gains, especially since markets have held up well despite recent problems. Strategists see real value despite FOMO behavior Market analysts have noticed this fear of missing out behavior. Still, they believe genuine value exists in certain AI investments. Julien Lafargue is chief market strategist at Barclays Private Bank and Wealth Management. He pointed out that the ECB’s review aims to highlight possible threats to financial stability, even when the chances of these threats actually happening are small. Prices aren’t cheap, he told CNBC, but companies are showing real growth. Lafargue stressed the need to look carefully at different sectors. The real danger? Companies whose stock prices have jumped without producing any actual earnings yet. He specifically mentioned quantum computing companies. In these situations, investor decisions seem based more on hope than real results, he noted. While fear of missing out might push some prices higher, others reflect genuine earnings growth. That makes careful selection crucial, Lafargue added. Turbulent weeks follow Nvidia earnings The ECB…

AI stock surge raises FOMO warnings from market experts

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Stock prices tied to artificial intelligence companies might be climbing partly because investors are scared of missing the rally. But financial experts say now’s not the time to bail out.

The European Central Bank put out its Financial Stability Review on Wednesday. The report shows worldwide stock markets sitting at consistently high levels. There’s a catch though, a small group of connected American technology giants now dominate the market. That concentration creates conditions where prices could suddenly drop.

These dominant players, often called hyperscalers, include Nvidia, Alphabet, Microsoft, and Meta.

Current stock prices don’t seem to account for the ongoing risks and uncertain conditions in the market, according to the review.

Investors might be feeling hopeful that worst-case scenarios won’t happen. But these price movements could also show people are afraid of missing out on further gains, especially since markets have held up well despite recent problems.

Strategists see real value despite FOMO behavior

Market analysts have noticed this fear of missing out behavior. Still, they believe genuine value exists in certain AI investments.

Julien Lafargue is chief market strategist at Barclays Private Bank and Wealth Management. He pointed out that the ECB’s review aims to highlight possible threats to financial stability, even when the chances of these threats actually happening are small.

Prices aren’t cheap, he told CNBC, but companies are showing real growth. Lafargue stressed the need to look carefully at different sectors. The real danger? Companies whose stock prices have jumped without producing any actual earnings yet. He specifically mentioned quantum computing companies.

In these situations, investor decisions seem based more on hope than real results, he noted.

While fear of missing out might push some prices higher, others reflect genuine earnings growth. That makes careful selection crucial, Lafargue added.

Turbulent weeks follow Nvidia earnings

The ECB report comes after several turbulent weeks for international stocks. Nvidia’s earnings announcement initially lifted the broader market, which had been under pressure from complex deal structures, debt offerings, and high prices. The technology company’s shares first jumped after the announcement but then quickly reversed course.

Investors can’t agree on whether an AI-driven investment bubble exists. One investor even claims there’s an “everything bubble.” Ray Dalio, who founded Bridgewater Associates, voiced worries. Larry Fink from BlackRock questioned whether massive spending on AI infrastructure is necessary. Cathie Wood from Ark Invest dismissed bubble talk altogether.

The ECB joins other central banks calling for caution. The Bank of England and International Monetary Fund issued similar warnings earlier.

The European central bank stopped short of declaring a bubble but drew comparisons to the dot-com boom and collapse. Current high prices appear supported by unusually strong earnings results, it added.

Luis de Guindos, vice president of the ECB, wrote in the report that market attitudes could change quickly. This could happen if growth expectations worsen or if technology company earnings, particularly those from artificial intelligence firms, don’t meet expectations.

Non-bank financial organizations in the euro area would probably suffer losses under such conditions because of their heavy investments in American companies, he mentioned. Mismatches in liquidity for open-ended investment funds, high borrowing levels among hedge funds, and lack of transparency in private markets could make market stress worse, De Guindos added.

Magnificent 7 dominate but raise concerns

The “Magnificent 7” stocks – Alphabet, Amazon, Apple, Tesla, Meta, Microsoft, and Nvidia – have risen 24% so far this year. As reported by Cryptopolitan. Cryptocurrency markets have shown instability, with a major selloff this month hitting Bitcoin and Ethereum particularly hard.

Michael Field is chief equity strategist at Morningstar. He said the ECB makes a valid point. The Magnificent 7 represents 40% of the Morningstar US index. That’s dangerous concentration. All seven companies have significant AI connections, adding another risk layer.

Morningstar sees potential gains in most of these major companies, though. Tesla stands out as more than 50% overvalued, Field stated.

Other AI-linked stocks have stretched valuations too. British favorite ARM Holdings trades at almost 90 times projected 2026 earnings, double Nvidia’s multiple. That’s certainly a risk, he acknowledged.

Get seen where it counts. Advertise in Cryptopolitan Research and reach crypto’s sharpest investors and builders.

Source: https://www.cryptopolitan.com/market-experts-ai-stock-surge-signs-fomo/

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
Why YouCam AI API is the Secret Weapon for E-Commerce Startups

Why YouCam AI API is the Secret Weapon for E-Commerce Startups

 The New Standard of Personalized Shopping In an era where digital engagement dictates market share, the transition from “browsing” to “buying” depends on confidence
Share
Techbullion2026/03/25 14:34
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26